Medicare Enrolled

Dr. Josier Nisnisan, MD

Internal Medicine · Sugar Land, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1400 CREEK WAY DR STE 201A, Sugar Land, TX 77478
2812012096
In practice since 2007 (18 years)
NPI: 1639391527 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nisnisan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nisnisan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nisnisan

Dr. Josier Nisnisan is an internal medicine specialist in Sugar Land, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Nisnisan performed 4,597 Medicare services across 810 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nisnisan received a total of $26,612 from 54 pharmaceutical and/or device companies across 974 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nisnisan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 7% volume in TX $26,612 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,597
Medicare services
Top 7% in TX for internal medicine
810
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~255 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Professional service for preparation and provision of single-dose vial of allergen 2,421 $13 $24
Hospital follow-up visit, moderate complexity 681 $61 $139
Allergy skin test 560 $3 $8
Office visit, established patient (30-39 min) 212 $80 $158
Allergy immunotherapy preparation 80 $9 $23
Hospital discharge day management, 30 minutes or less 70 $64 $159
Initial hospital admission, high complexity 65 $134 $357
Ultrasound study of arm and leg arteries 41 $64 $184
Ultrasound of both sides of head and neck blood flow 39 $146 $600
Echocardiogram, transthoracic 38 $149 $1,500
Ultrasound of leg arteries or artery grafts 38 $182 $500
Ultrasound study of arm or leg veins with compression and maneuvers 38 $116 $450
Complete ultrasound of abdomen and pelvis artery and vein blood flow 36 $207 $500
Office visit, established patient (20-29 min) 36 $58 $103
Complete ultrasound scan behind abdominal cavity 35 $84 $250
Evaluation of neuropsychological test, first hour 24 $98 $155
Administration of psychological or neuropsychological test by technician, first 30 minutes 24 $26 $60
Administration of psychological or neuropsychological test by technician, each additional 30 minutes 24 $27 $60
Evaluation of brain response to sound for determination of hearing threshold with interpretation and report 22 $86 $175
Electrocardiogram (ecg) 1 to 3 leads with review by physician 21 $9 $30
Measurement of brain wave activity (eeg), awake and drowsy 21 $297 $400
Measurement of nerve conduction using visual stimulation testing with report 21 $52 $90
Measurement of brain wave activity (eeg), digital analysis 21 $214 $300
Annual wellness visit, follow-up 17 $126 $185
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and 12 $41 $105
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
5.9% medium
93.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$26,612
Total received (2018-2024)
Avg $3,802/year across 7 years
Top 4% in TX for internal medicine
54
Companies
974
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,612 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,415
2023
$2,809
2022
$3,515
2021
$3,181
2020
$2,045
2019
$6,650
2018
$4,997

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$7,102
Novo Nordisk Inc
$2,533
Amgen Inc.
$2,192
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,968
PFIZER INC.
$1,313
Amarin Pharma Inc.
$1,260
Novartis Pharmaceuticals Corporation
$1,062
Lilly USA, LLC
$975
SANOFI-AVENTIS U.S. LLC
$860
GlaxoSmithKline, LLC.
$852
Janssen Pharmaceuticals, Inc
$711
Bayer HealthCare Pharmaceuticals Inc.
$711
ABBVIE INC.
$683
Esperion Therapeutics, Inc.
$541
Merck Sharp & Dohme LLC
$415
Allergan Inc.
$283
Bayer Healthcare Pharmaceuticals Inc.
$281
AbbVie Inc.
$257
E.R. Squibb & Sons, L.L.C.
$220
Astellas Pharma US Inc
$179
Boston Scientific Corporation
$155
Kowa Pharmaceuticals America, Inc.
$155
Allergan, Inc.
$153
Abbott Laboratories
$147
SI-BONE, Inc.
$140
Sunovion Pharmaceuticals Inc.
$137
Relypsa, Inc.
$124
Otsuka America Pharmaceutical, Inc.
$116
Regeneron Pharmaceuticals, Inc.
$112
IBSA Pharma Inc.
$88
Phathom Pharmaceuticals, Inc.
$88
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$83
Corcept Therapeutics
$63
Merck Sharp & Dohme Corporation
$63
ARBOR PHARMACEUTICALS, INC.
$54
Janssen Scientific Affairs, LLC
$49
West-Ward Pharmaceuticals
$45
Regeneron Healthcare Solutions, Inc.
$43
Dexcom, Inc.
$42
Mylan Specialty L.P.
$40
Bardy Diagnostics, Inc.
$40
Lexicon Pharmaceuticals, Inc.
$36
Althera Pharmaceuticals LLC
$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$26
Azurity Pharmaceuticals, Inc.
$24
Radius Health, Inc.
$21
Medtronic MiniMed, Inc.
$21
Biohaven Pharmaceuticals, Inc.
$20
Biohaven Pharmaceutical Holding Company Ltd.
$19
Janssen Biotech, Inc.
$18
Exact Sciences Corporation
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Arbor Pharmaceuticals, Inc.
$15
SCILEX PHARMACEUTICALS INC.
$12
Top 3 companies account for 44.4% of total payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Bidil · CAPLYTA · CHANTIX · Carnation Ambulatory Monitor · Cologuard Collection Kit · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · EkoSonic · FARXIGA · FASENRA · FIASP · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · HORIZANT · HUMALOG · INVOKANA · Inpefa · JANUVIA · JARDIANCE · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PRALUENT · PROCLAIM · Prolia · QULIPTA · REXULTI · RYBELSUS · Repatha · Roszet · Rybelsus · SEGLENTIS · SHINGRIX · SIMPONI · SOLIQUA · SOLIQUA 100/33 · SYMBICORT · SYNJARDY · Saxenda · TAVNEOS · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tirosint · Tresiba · Tymlos · UBRELVY · Uloric · Utibron · VERQUVO · VOQUEZNA · VRAYLAR · Vascepa · Veltassa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · Yupelri · ZEPBOUND · ZTLido · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in TX.

Equivalent to $579 per 100 Medicare services performed
Looking for an internal medicine specialist in Sugar Land?
Compare internal medicine physicians in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,335
Per 100K population
271.6
County median income
$113,409
Nearest hospital
ST LUKE'S SUGAR LAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nisnisan is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), with low-engagement industry engagement in the top 4% of TX peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nisnisan experienced with professional service for preparation and provision of single-dose vial of allergen?
Based on Medicare claims data, Dr. Nisnisan performed 2,421 professional service for preparation and provision of single-dose vial of allergen services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nisnisan receive payments from pharmaceutical companies?
Yes. Dr. Nisnisan received a total of $26,612 from 54 companies across 974 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nisnisan's costs compare to other internal medicine physicians in Sugar Land?
Dr. Nisnisan's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nisnisan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →